<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2000-12-01" modified="2018-01-31" version="198">
<accession>O43318</accession>
<accession>B2RE27</accession>
<accession>E1P523</accession>
<accession>O43317</accession>
<accession>O43319</accession>
<accession>Q5TDN2</accession>
<accession>Q5TDN3</accession>
<accession>Q5TDT7</accession>
<accession>Q9NTR3</accession>
<accession>Q9NZ70</accession>
<name>M3K7_HUMAN</name>
<protein>
<recommendedName>
<fullName>Mitogen-activated protein kinase kinase kinase 7</fullName>
<ecNumber evidence="18 20 25">2.7.11.25</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Transforming growth factor-beta-activated kinase 1</fullName>
<shortName>TGF-beta-activated kinase 1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">MAP3K7</name>
<name type="synonym">TAK1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Biochem. Biophys. Res. Commun." volume="243" first="545" last="549">
<title>TGF-beta-activated kinase 1 stimulates NF-kappa B activation by an NF-kappa B-inducing kinase-independent mechanism.</title>
<authorList>
<person name="Sakurai H."/>
<person name="Shigemori N."/>
<person name="Hasegawa K."/>
<person name="Sugita T."/>
</authorList>
<dbReference type="PubMed" id="9480845"/>
<dbReference type="DOI" id="10.1006/bbrc.1998.8124"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1A; 1B AND 1C)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2000" name="Biochim. Biophys. Acta" volume="1517" first="46" last="52">
<title>Alternative splicing and gene structure of the transforming growth factor beta-activated kinase 1.</title>
<authorList>
<person name="Dempsey C.E."/>
<person name="Sakurai H."/>
<person name="Sugita T."/>
<person name="Guesdon F."/>
</authorList>
<dbReference type="PubMed" id="11118615"/>
<dbReference type="DOI" id="10.1016/S0167-4781(00)00258-X"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1D)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="submission" date="2005-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1A)</scope>
<source>
<tissue>Trachea</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1A)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="13675" last="13679">
<title>A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3.</title>
<authorList>
<person name="Moriguchi T."/>
<person name="Kuroyanagi N."/>
<person name="Yamaguchi K."/>
<person name="Gotoh Y."/>
<person name="Irie K."/>
<person name="Kano T."/>
<person name="Shirakabe K."/>
<person name="Muro Y."/>
<person name="Shibuya H."/>
<person name="Matsumoto K."/>
<person name="Nishida E."/>
<person name="Hagiwara M."/>
</authorList>
<dbReference type="PubMed" id="8663074"/>
<dbReference type="DOI" id="10.1074/jbc.271.23.13675"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF MAP2K3/MKK3 AND MAP2K6/MKK6</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1996" name="Science" volume="272" first="1179" last="1182">
<title>TAB1: an activator of the TAK1 MAPKKK in TGF-beta signal transduction.</title>
<authorList>
<person name="Shibuya H."/>
<person name="Yamaguchi K."/>
<person name="Shirakabe K."/>
<person name="Tonegawa A."/>
<person name="Gotoh Y."/>
<person name="Ueno N."/>
<person name="Irie K."/>
<person name="Nishida E."/>
<person name="Matsumoto K."/>
</authorList>
<dbReference type="PubMed" id="8638164"/>
<dbReference type="DOI" id="10.1126/science.272.5265.1179"/>
</citation>
<scope>INTERACTION WITH TAB1/MAP3K7IP1</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="8141" last="8144">
<title>TAK1 mediates the ceramide signaling to stress-activated protein kinase/c-Jun N-terminal kinase.</title>
<authorList>
<person name="Shirakabe K."/>
<person name="Yamaguchi K."/>
<person name="Shibuya H."/>
<person name="Irie K."/>
<person name="Matsuda S."/>
<person name="Moriguchi T."/>
<person name="Gotoh Y."/>
<person name="Matsumoto K."/>
<person name="Nishida E."/>
</authorList>
<dbReference type="PubMed" id="9079627"/>
<dbReference type="DOI" id="10.1074/jbc.272.13.8141"/>
</citation>
<scope>ENZYME REGULATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="Nature" volume="398" first="252" last="256">
<title>The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway.</title>
<authorList>
<person name="Ninomiya-Tsuji J."/>
<person name="Kishimoto K."/>
<person name="Hiyama A."/>
<person name="Inoue J."/>
<person name="Cao Z."/>
<person name="Matsumoto K."/>
</authorList>
<dbReference type="PubMed" id="10094049"/>
<dbReference type="DOI" id="10.1038/18465"/>
</citation>
<scope>INTERACTION WITH TRAF6 AND TAB1/MAP3K7IP1</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="FEBS Lett." volume="474" first="141" last="145">
<title>Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by TAB1.</title>
<authorList>
<person name="Sakurai H."/>
<person name="Miyoshi H."/>
<person name="Mizukami J."/>
<person name="Sugita T."/>
</authorList>
<dbReference type="PubMed" id="10838074"/>
<dbReference type="DOI" id="10.1016/S0014-5793(00)01588-X"/>
</citation>
<scope>INTERACTION WITH TAB1</scope>
<scope>PHOSPHORYLATION AT THR-184; THR-187 AND SER-192</scope>
<scope>ACTIVATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="7359" last="7364">
<title>TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop.</title>
<authorList>
<person name="Kishimoto K."/>
<person name="Matsumoto K."/>
<person name="Ninomiya-Tsuji J."/>
</authorList>
<dbReference type="PubMed" id="10702308"/>
<dbReference type="DOI" id="10.1074/jbc.275.10.7359"/>
</citation>
<scope>PHOSPHORYLATION AT SER-192</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="5753" last="5759">
<title>Regulation of the TAK1 signaling pathway by protein phosphatase 2C.</title>
<authorList>
<person name="Hanada M."/>
<person name="Ninomiya-Tsuji J."/>
<person name="Komaki K."/>
<person name="Ohnishi M."/>
<person name="Katsura K."/>
<person name="Kanamaru R."/>
<person name="Matsumoto K."/>
<person name="Tamura S."/>
</authorList>
<dbReference type="PubMed" id="11104763"/>
<dbReference type="DOI" id="10.1074/jbc.M007773200"/>
</citation>
<scope>DEPHOSPHORYLATION BY PPM1B/PP2CB</scope>
<scope>INTERACTION WITH PPM1B/PP2CB</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2001" name="Nature" volume="412" first="346" last="351">
<title>TAK1 is a ubiquitin-dependent kinase of MKK and IKK.</title>
<authorList>
<person name="Wang C."/>
<person name="Deng L."/>
<person name="Hong M."/>
<person name="Akkaraju G.R."/>
<person name="Inoue J."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="11460167"/>
<dbReference type="DOI" id="10.1038/35085597"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH TAB1/MAP3K7IP2 AND TAB2/MAP3K7IP2</scope>
<scope>IDENTIFICATION IN THE TRIKA2 COMPLEX</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="7158" last="7167">
<title>Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.</title>
<authorList>
<person name="Jiang Z."/>
<person name="Ninomiya-Tsuji J."/>
<person name="Qian Y."/>
<person name="Matsumoto K."/>
<person name="Li X."/>
</authorList>
<dbReference type="PubMed" id="12242293"/>
<dbReference type="DOI" id="10.1128/MCB.22.20.7158-7167.2002"/>
</citation>
<scope>INTERACTION WITH IRAK; TAB1/MAP3K7IP1; TAB2/MAP3K7IP2 AND TRAF6</scope>
<scope>PHOSPHORYLATION</scope>
<scope>ENZYME REGULATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="FEBS Lett." volume="545" first="199" last="202">
<title>Pellino2 activates the mitogen activated protein kinase pathway.</title>
<authorList>
<person name="Jensen L.E."/>
<person name="Whitehead A.S."/>
</authorList>
<dbReference type="PubMed" id="12804775"/>
<dbReference type="DOI" id="10.1016/S0014-5793(03)00533-7"/>
</citation>
<scope>INTERACTION WITH PELI1 AND PELI2</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2003" name="J. Immunol." volume="171" first="1500" last="1506">
<title>Pellino3, a novel member of the Pellino protein family, promotes activation of c-Jun and Elk-1 and may act as a scaffolding protein.</title>
<authorList>
<person name="Jensen L.E."/>
<person name="Whitehead A.S."/>
</authorList>
<dbReference type="PubMed" id="12874243"/>
<dbReference type="DOI" id="10.4049/jimmunol.171.3.1500"/>
</citation>
<scope>INTERACTION WITH PELI3</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2003" name="Mol. Biol. Cell" volume="14" first="529" last="544">
<title>Transforming growth factor-beta1 (TGF-beta)-induced apoptosis of prostate cancer cells involves Smad7-dependent activation of p38 by TGF-beta-activated kinase 1 and mitogen-activated protein kinase kinase 3.</title>
<authorList>
<person name="Edlund S."/>
<person name="Bu S."/>
<person name="Schuster N."/>
<person name="Aspenstroem P."/>
<person name="Heuchel R."/>
<person name="Heldin N.E."/>
<person name="ten Dijke P."/>
<person name="Heldin C.H."/>
<person name="Landstrom M."/>
</authorList>
<dbReference type="PubMed" id="12589052"/>
<dbReference type="DOI" id="10.1091/mbc.02-03-0037"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SMAD7; MAP2K3 AND P38 KINASE</scope>
<scope>MUTAGENESIS OF LYS-63</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="Biochem. J." volume="378" first="27" last="34">
<title>TAB3, a new binding partner of the protein kinase TAK1.</title>
<authorList>
<person name="Cheung P.C."/>
<person name="Nebreda A.R."/>
<person name="Cohen P."/>
</authorList>
<dbReference type="PubMed" id="14670075"/>
<dbReference type="DOI" id="10.1042/BJ20031794"/>
</citation>
<scope>INTERACTION WITH TAB3/MAP3K7IP3</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="25920" last="25927">
<title>Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway.</title>
<authorList>
<person name="Hocevar B.A."/>
<person name="Prunier C."/>
<person name="Howe P.H."/>
</authorList>
<dbReference type="PubMed" id="15894542"/>
<dbReference type="DOI" id="10.1074/jbc.M501150200"/>
</citation>
<scope>INTERACTION WITH DAB2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="EMBO Rep." volume="7" first="838" last="844">
<title>The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway.</title>
<authorList>
<person name="Thiefes A."/>
<person name="Wolf A."/>
<person name="Doerrie A."/>
<person name="Grassl G.A."/>
<person name="Matsumoto K."/>
<person name="Autenrieth I."/>
<person name="Bohn E."/>
<person name="Sakurai H."/>
<person name="Niedenthal R."/>
<person name="Resch K."/>
<person name="Kracht M."/>
</authorList>
<dbReference type="PubMed" id="16845370"/>
<dbReference type="DOI" id="10.1038/sj.embor.7400754"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>PHOSPHORYLATION AT THR-187 BY AUTOCATALYSIS</scope>
<scope>SUBUNIT</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="28802" last="28810">
<title>Osmotic stress activates the TAK1-JNK pathway while blocking TAK1-mediated NF-kappaB activation: TAO2 regulates TAK1 pathways.</title>
<authorList>
<person name="Huangfu W.C."/>
<person name="Omori E."/>
<person name="Akira S."/>
<person name="Matsumoto K."/>
<person name="Ninomiya-Tsuji J."/>
</authorList>
<dbReference type="PubMed" id="16893890"/>
<dbReference type="DOI" id="10.1074/jbc.M603627200"/>
</citation>
<scope>FUNCTION</scope>
<scope>ENZYME REGULATION</scope>
<scope>INTERACTION WITH TAOK1 AND TAOK2</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="39891" last="39896">
<title>Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway.</title>
<authorList>
<person name="Kajino T."/>
<person name="Ren H."/>
<person name="Iemura S."/>
<person name="Natsume T."/>
<person name="Stefansson B."/>
<person name="Brautigan D.L."/>
<person name="Matsumoto K."/>
<person name="Ninomiya-Tsuji J."/>
</authorList>
<dbReference type="PubMed" id="17079228"/>
<dbReference type="DOI" id="10.1074/jbc.M608155200"/>
</citation>
<scope>INTERACTION WITH PP2A AND PPP6C</scope>
<scope>DEPHOSPHORYLATION AT THR-187 BY PP2A AND PPP6C</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="16776" last="16782">
<title>RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.</title>
<authorList>
<person name="Tian Y."/>
<person name="Zhang Y."/>
<person name="Zhong B."/>
<person name="Wang Y.Y."/>
<person name="Diao F.C."/>
<person name="Wang R.P."/>
<person name="Zhang M."/>
<person name="Chen D.Y."/>
<person name="Zhai Z.H."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="17449468"/>
<dbReference type="DOI" id="10.1074/jbc.M701913200"/>
</citation>
<scope>INTERACTION WITH RBCK1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Exp. Med." volume="204" first="1475" last="1485">
<title>Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.</title>
<authorList>
<person name="Reiley W.W."/>
<person name="Jin W."/>
<person name="Lee A.J."/>
<person name="Wright A."/>
<person name="Wu X."/>
<person name="Tewalt E.F."/>
<person name="Leonard T.O."/>
<person name="Norbury C.C."/>
<person name="Fitzpatrick L."/>
<person name="Zhang M."/>
<person name="Sun S.C."/>
</authorList>
<dbReference type="PubMed" id="17548520"/>
<dbReference type="DOI" id="10.1084/jem.20062694"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>INTERACTION WITH CYLD</scope>
<scope>DEUBIQUITINATION BY CYLD</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="526" last="534">
<title>Phosphoproteome of resting human platelets.</title>
<authorList>
<person name="Zahedi R.P."/>
<person name="Lewandrowski U."/>
<person name="Wiesner J."/>
<person name="Wortelkamp S."/>
<person name="Moebius J."/>
<person name="Schuetz C."/>
<person name="Walter U."/>
<person name="Gambaryan S."/>
<person name="Sickmann A."/>
</authorList>
<dbReference type="PubMed" id="18088087"/>
<dbReference type="DOI" id="10.1021/pr0704130"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Platelet</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Mol. Cell" volume="31" first="438" last="448">
<title>Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.</title>
<authorList>
<person name="Daub H."/>
<person name="Olsen J.V."/>
<person name="Bairlein M."/>
<person name="Gnad F."/>
<person name="Oppermann F.S."/>
<person name="Korner R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Stemmann O."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="18691976"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.07.007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Nat. Cell Biol." volume="10" first="1199" last="1207">
<title>The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.</title>
<authorList>
<person name="Sorrentino A."/>
<person name="Thakur N."/>
<person name="Grimsby S."/>
<person name="Marcusson A."/>
<person name="von Bulow V."/>
<person name="Schuster N."/>
<person name="Zhang S."/>
<person name="Heldin C.H."/>
<person name="Landstrom M."/>
</authorList>
<dbReference type="PubMed" id="18758450"/>
<dbReference type="DOI" id="10.1038/ncb1780"/>
</citation>
<scope>INTERACTION WITH TGFBR1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E1660" last="E1660">
<title>Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein.</title>
<authorList>
<person name="Blanco S."/>
<person name="Sanz-Garcia M."/>
<person name="Santos C.R."/>
<person name="Lazo P.A."/>
</authorList>
<dbReference type="PubMed" id="18286207"/>
<dbReference type="DOI" id="10.1371/journal.pone.0001660"/>
</citation>
<scope>INTERACTION WITH VRK2</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Cell. Mol. Life Sci." volume="66" first="2573" last="2584">
<title>WDR34 is a novel TAK1-associated suppressor of the IL-1R/TLR3/TLR4-induced NF-kappaB activation pathway.</title>
<authorList>
<person name="Gao D."/>
<person name="Wang R."/>
<person name="Li B."/>
<person name="Yang Y."/>
<person name="Zhai Z."/>
<person name="Chen D.Y."/>
</authorList>
<dbReference type="PubMed" id="19521662"/>
<dbReference type="DOI" id="10.1007/s00018-009-0059-6"/>
</citation>
<scope>INTERACTION WITH WDR34</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2009" name="Nature" volume="461" first="114" last="119">
<title>Direct activation of protein kinases by unanchored polyubiquitin chains.</title>
<authorList>
<person name="Xia Z.-P."/>
<person name="Sun L."/>
<person name="Chen X."/>
<person name="Pineda G."/>
<person name="Jiang X."/>
<person name="Adhikari A."/>
<person name="Zeng W."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="19675569"/>
<dbReference type="DOI" id="10.1038/nature08247"/>
</citation>
<scope>INTERACTION WITH TAB2</scope>
<scope>PHOSPHORYLATION AT THR-187</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="3214" last="3226">
<title>Ubiquitin-mediated activation of TAK1 and IKK.</title>
<authorList>
<person name="Adhikari A."/>
<person name="Xu M."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="17496917"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210413"/>
</citation>
<scope>REVIEW ON ENZYME REGULATION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="39">
<citation type="journal article" date="2010" name="Int. J. Biochem. Cell Biol." volume="42" first="585" last="589">
<title>The TAK1-TRAF6 signalling pathway.</title>
<authorList>
<person name="Landstrom M."/>
</authorList>
<dbReference type="PubMed" id="20060931"/>
<dbReference type="DOI" id="10.1016/j.biocel.2009.12.023"/>
</citation>
<scope>REVIEW ON ENZYME REGULATION</scope>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="19341" last="19346">
<title>Tripartite motif 8 (TRIM8) modulates TNFalpha- and IL-1beta-triggered NF-kappaB activation by targeting TAK1 for K63-linked polyubiquitination.</title>
<authorList>
<person name="Li Q."/>
<person name="Yan J."/>
<person name="Mao A.P."/>
<person name="Li C."/>
<person name="Ran Y."/>
<person name="Shu H.B."/>
<person name="Wang Y.Y."/>
</authorList>
<dbReference type="PubMed" id="22084099"/>
<dbReference type="DOI" id="10.1073/pnas.1110946108"/>
</citation>
<scope>INTERACTION WITH TRIM8</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="Nature" volume="472" first="361" last="365">
<title>TRIM5 is an innate immune sensor for the retrovirus capsid lattice.</title>
<authorList>
<person name="Pertel T."/>
<person name="Hausmann S."/>
<person name="Morger D."/>
<person name="Zueger S."/>
<person name="Guerra J."/>
<person name="Lascano J."/>
<person name="Reinhard C."/>
<person name="Santoni F.A."/>
<person name="Uchil P.D."/>
<person name="Chatel L."/>
<person name="Bisiaux A."/>
<person name="Albert M.L."/>
<person name="Strambio-De-Castillia C."/>
<person name="Mothes W."/>
<person name="Pizzato M."/>
<person name="Gruetter M.G."/>
<person name="Luban J."/>
</authorList>
<dbReference type="PubMed" id="21512573"/>
<dbReference type="DOI" id="10.1038/nature09976"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TRIM5</scope>
<scope>PHOSPHORYLATION AT THR-187</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-389 AND SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2012" name="Cell. Signal." volume="24" first="1381" last="1389">
<title>Lys48-linked TAK1 polyubiquitination at lysine-72 downregulates TNFalpha-induced NF-kappaB activation via mediating TAK1 degradation.</title>
<authorList>
<person name="Fan Y."/>
<person name="Shi Y."/>
<person name="Liu S."/>
<person name="Mao R."/>
<person name="An L."/>
<person name="Zhao Y."/>
<person name="Zhang H."/>
<person name="Zhang F."/>
<person name="Xu G."/>
<person name="Qin J."/>
<person name="Yang J."/>
</authorList>
<dbReference type="PubMed" id="22406003"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2012.02.017"/>
</citation>
<scope>UBIQUITINATION AT LYS-72</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-367; SER-389; SER-439 AND SER-455</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2015" name="Cell. Signal." volume="27" first="2343" last="2354">
<title>IFIT5 positively regulates NF-kappaB signaling through synergizing the recruitment of IkappaB kinase (IKK) to TGF-beta-activated kinase 1 (TAK1).</title>
<authorList>
<person name="Zheng C."/>
<person name="Zheng Z."/>
<person name="Zhang Z."/>
<person name="Meng J."/>
<person name="Liu Y."/>
<person name="Ke X."/>
<person name="Hu Q."/>
<person name="Wang H."/>
</authorList>
<dbReference type="PubMed" id="26334375"/>
<dbReference type="DOI" id="10.1016/j.cellsig.2015.08.018"/>
</citation>
<scope>INTERACTION WITH IFIT5</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="99" first="392" last="406">
<title>Mutations in MAP3K7 that alter the activity of the TAK1 signaling complex cause frontometaphyseal dysplasia.</title>
<authorList>
<person name="Wade E.M."/>
<person name="Daniel P.B."/>
<person name="Jenkins Z.A."/>
<person name="McInerney-Leo A."/>
<person name="Leo P."/>
<person name="Morgan T."/>
<person name="Addor M.C."/>
<person name="Ades L.C."/>
<person name="Bertola D."/>
<person name="Bohring A."/>
<person name="Carter E."/>
<person name="Cho T.J."/>
<person name="Duba H.C."/>
<person name="Fletcher E."/>
<person name="Kim C.A."/>
<person name="Krakow D."/>
<person name="Morava E."/>
<person name="Neuhann T."/>
<person name="Superti-Furga A."/>
<person name="Veenstra-Knol I."/>
<person name="Wieczorek D."/>
<person name="Wilson L.C."/>
<person name="Hennekam R.C."/>
<person name="Sutherland-Smith A.J."/>
<person name="Strom T.M."/>
<person name="Wilkie A.O."/>
<person name="Brown M.A."/>
<person name="Duncan E.L."/>
<person name="Markie D.M."/>
<person name="Robertson S.P."/>
</authorList>
<dbReference type="PubMed" id="27426733"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.05.024"/>
</citation>
<scope>INVOLVEMENT IN FMD2</scope>
<scope>VARIANTS FMD2 GLN-70; GLU-100; ARG-168 AND LEU-512</scope>
<scope>CHARACTERIZATION OF VARIANTS FMD2 LEU-512 AND ARG-168</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF PRO-512</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2016" name="Am. J. Hum. Genet." volume="99" first="407" last="413">
<title>Heterozygous mutations in MAP3K7, encoding TGF-beta-activated kinase 1, cause cardiospondylocarpofacial syndrome.</title>
<authorList>
<person name="Le Goff C."/>
<person name="Rogers C."/>
<person name="Le Goff W."/>
<person name="Pinto G."/>
<person name="Bonnet D."/>
<person name="Chrabieh M."/>
<person name="Alibeu O."/>
<person name="Nistchke P."/>
<person name="Munnich A."/>
<person name="Picard C."/>
<person name="Cormier-Daire V."/>
</authorList>
<dbReference type="PubMed" id="27426734"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2016.06.005"/>
</citation>
<scope>INVOLVEMENT IN CSCF</scope>
<scope>VARIANTS CSCF VAL-50 DEL; CYS-110 AND ARG-241</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2017" name="Sci. Rep." volume="7" first="8396" last="8396">
<title>The Us2 Gene Product of herpes dimplex virus 2 modulates NF-kappaB activation by targeting TAK1.</title>
<authorList>
<person name="Lu X."/>
<person name="Huang C."/>
<person name="Zhang Y."/>
<person name="Lin Y."/>
<person name="Wang X."/>
<person name="Li Q."/>
<person name="Liu S."/>
<person name="Tang J."/>
<person name="Zhou L."/>
</authorList>
<dbReference type="PubMed" id="28827540"/>
<dbReference type="DOI" id="10.1038/s41598-017-08856-4"/>
</citation>
<scope>INTERACTION WITH HHV-2 PROTEIN US2</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2005" name="J. Mol. Biol." volume="354" first="1013" last="1020">
<title>Structural basis for the interaction of TAK1 kinase with its activating protein TAB1.</title>
<authorList>
<person name="Brown K."/>
<person name="Vial S.C."/>
<person name="Dedi N."/>
<person name="Long J.M."/>
<person name="Dunster N.J."/>
<person name="Cheetham G.M.T."/>
</authorList>
<dbReference type="PubMed" id="16289117"/>
<dbReference type="DOI" id="10.1016/j.jmb.2005.09.098"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 31-328 IN COMPLEX WITH TAB1 AND ADENOSINE</scope>
</reference>
<comment type="function">
<text evidence="18 23 25 31 32 40 48 49">Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. Plays an important role in the cascades of cellular responses evoked by changes in the environment. Mediates signal transduction of TRAF6, various cytokines including interleukin-1 (IL-1), transforming growth factor-beta (TGFB), TGFB-related factors like BMP2 and BMP4, toll-like receptors (TLR), tumor necrosis factor receptor CD40 and B-cell receptor (BCR). Ceramides are also able to activate MAP3K7/TAK1. Once activated, acts as an upstream activator of the MKK/JNK signal transduction cascade and the p38 MAPK signal transduction cascade through the phosphorylation and activation of several MAP kinase kinases like MAP2K1/MEK1, MAP2K3/MKK3, MAP2K6/MKK6 and MAP2K7/MKK7. These MAP2Ks in turn activate p38 MAPKs, c-jun N-terminal kinases (JNKs) and I-kappa-B kinase complex (IKK). Both p38 MAPK and JNK pathways control the transcription factors activator protein-1 (AP-1), while nuclear factor-kappa B is activated by IKK. MAP3K7 activates also IKBKB and MAPK8/JNK1 in response to TRAF6 signaling and mediates BMP2-induced apoptosis. In osmotic stress signaling, plays a major role in the activation of MAPK8/JNK1, but not that of NF-kappa-B. Promotes TRIM5 capsid-specific restriction activity.</text>
</comment>
<comment type="catalytic activity">
<text evidence="18 20 25">ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="cofactor">
<cofactor>
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="19 23 24 32 49">Activated by proinflammatory cytokines and in response to physical and chemical stresses, including osmotic stress, oxidative stress, arsenic and ultraviolet light irradiation. Activated by 'Lys-63'-linked polyubiquitination and by autophosphorylation. Association with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2 promotes activation through autophosphorylation, whereas PPM1B/PP2CB, PP2A and PPP6C dephosphorylation leads to inactivation.</text>
</comment>
<comment type="subunit">
<text evidence="15 18 20 21 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 43 44 47">Can form homodimer (PubMed:27426733). Binds both upstream activators and downstream substrates in multimolecular complexes. Interacts with TAB1/MAP3K7IP1, TAB2/MAP3K7IP2 and TAB3/MAP3K7IP3 (PubMed:10838074, PubMed:11460167, PubMed:12242293, PubMed:14670075, PubMed:16289117, PubMed:19675569, PubMed:8638164). Identified in the TRIKA2 complex composed of MAP3K7/TAK1, TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2 (PubMed:11460167). Interacts with PPM1L and PPM1B/PP2CB (PubMed:11104763). Interaction with PP2A and PPP6C leads to its repressed activity (PubMed:17079228). Interacts with TRAF6 and TAB1/MAP3K7IP1; during IL-1 signaling (PubMed:10094049, PubMed:12242293). Interacts with TAOK1 and TAOK2; interaction with TAOK2 interferes with MAP3K7 interaction with IKKA, thus preventing NF-kappa-B activation (PubMed:16893890). Interacts with WDR34 (via WD domains) (PubMed:19521662). Interacts with CYLD and RBCK1 (PubMed:17449468, PubMed:17548520). Interacts with TGFBR1; induces MAP3K7/TAK1 activation by TRAF6 (PubMed:18758450). Interacts with MAPK8IP1 and SMAD6 (By similarity). Interacts with isoform 1 of VRK2 (PubMed:18286207). Interacts with DAB2; the interaction is induced by TGF-beta stimulation and may mediate TGF-beta stimulated JNK activation (PubMed:15894542). Interacts with TRIM5 (PubMed:21512573). Part of a complex containing ITCH, NDFIP1 and MAP3K7 (By similarity). Interacts with IFIT5; the interaction synergizes the recruitment of IKK to MAP3K7 and enhances IKK phosphorylation (PubMed:26334375). Interacts with PLEKHM1 (via N- and C-terminus) (By similarity). Interacts with TRIM8 (PubMed:22084099).</text>
</comment>
<comment type="subunit">
<text evidence="46">(Microbial infection) Interacts with herpes simplex virus 2 protein US2; this interaction induced MAP3K7 phosphorylation and subsequent actviation.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-7287204">
<id>B5Z6S0</id>
<label>cagA</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358700"/>
<interactant intactId="EBI-295634">
<id>Q16543</id>
<label>CDC37</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358700"/>
<interactant intactId="EBI-296047">
<id>P07900</id>
<label>HSP90AA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-492605">
<id>O14733</id>
<label>MAP2K7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-78404">
<id>Q9UQF2</id>
<label>MAPK8IP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-366978">
<id>Q9UBE8</id>
<label>NLK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-359751">
<id>O00743</id>
<label>PPP6C</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-518675">
<id>P40763</id>
<label>STAT3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-358643">
<id>Q15750</id>
<label>TAB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-358708">
<id>Q9NYJ8</id>
<label>TAB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-359964">
<id>Q8N5C8</id>
<label>TAB3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-1051794">
<id>Q9UKE5</id>
<label>TNIK</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-359276">
<id>Q9Y4K3</id>
<label>TRAF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358684"/>
<interactant intactId="EBI-3390054">
<id>P0CG48</id>
<label>UBC</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="24">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="24">Cell membrane</location>
<topology evidence="24">Peripheral membrane protein</topology>
<orientation evidence="24">Cytoplasmic side</orientation>
</subcellularLocation>
<text>Although the majority of MAP3K7/TAK1 is found in the cytosol, when complexed with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2, it is also localized at the cell membrane.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O43318-1</id>
<name>1B</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O43318-2</id>
<name>1A</name>
<sequence type="described" ref="VSP_004886"/>
</isoform>
<isoform>
<id>O43318-3</id>
<name>1C</name>
<sequence type="described" ref="VSP_004887 VSP_004888"/>
</isoform>
<isoform>
<id>O43318-4</id>
<name>1D</name>
<sequence type="described" ref="VSP_004886 VSP_004887 VSP_004888"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="22">Isoform 1A is the most abundant in ovary, skeletal muscle, spleen and blood mononuclear cells. Isoform 1B is highly expressed in brain, kidney and small intestine. Isoform 1C is the major form in prostate. Isoform 1D is the less abundant form.</text>
</comment>
<comment type="PTM">
<text evidence="19 20 31 35 39 40">Association with TAB1/MAP3K7IP1 promotes autophosphorylation at Ser-192 and subsequent activation. Association with TAB2/MAP3K7IP2, itself associated with free unanchored Lys-63 polyubiquitin chain, promotes autophosphorylation and subsequent activation of MAP3K7. Dephosphorylation at Ser-192 by PPM1B/PP2CB and at Thr-187 by PP2A and PPP6C leads to inactivation.</text>
</comment>
<comment type="PTM">
<text evidence="15 35 42">'Lys-48'-linked polyubiquitination at Lys-72 is induced by TNFalpha, and leads to proteasomal degradation. Undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH (By similarity). Requires 'Lys-63'-linked polyubiquitination for autophosphorylation and subsequent activation. 'Lys-63'-linked ubiquitination does not lead to proteasomal degradation. Deubiquitinated by CYLD, a protease that selectively cleaves 'Lys-63'-linked ubiquitin chains. Deubiquitinated by Y.enterocolitica YopP.</text>
</comment>
<comment type="disease" evidence="44">
<disease id="DI-04852">
<name>Frontometaphyseal dysplasia 2</name>
<acronym>FMD2</acronym>
<description>A form of frontometaphyseal dysplasia, a progressive sclerosing skeletal dysplasia affecting the long bones and skull. Characteristic features include supraorbital hyperostosis, cranial hyperostosis, undermodeling of the small bones, flared metaphyses, and digital anomalies. Extra-skeletal manifestations include hearing loss, cardiac malformations, and stenosis, particularly of the upper airway and urinary tract. FMD2 inheritance is autosomal dominant.</description>
<dbReference type="MIM" id="617137"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="45">
<disease id="DI-04853">
<name>Cardiospondylocarpofacial syndrome</name>
<acronym>CSCF</acronym>
<description>A syndrome characterized by growth retardation, dysmorphic facial features, brachydactyly with carpal-tarsal fusion and extensive posterior cervical vertebral synostosis, cardiac septal defects with valve dysplasia, and deafness with inner ear malformations. CSCF transmission pattern is consistent with autosomal dominant inheritance.</description>
<dbReference type="MIM" id="157800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="54">Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/MAP3K7ID454ch6q15.html"/>
</comment>
<dbReference type="EC" id="2.7.11.25" evidence="18 20 25"/>
<dbReference type="EMBL" id="AB009357">
<property type="protein sequence ID" value="BAA25026.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB009356">
<property type="protein sequence ID" value="BAA25025.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB009358">
<property type="protein sequence ID" value="BAA25027.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF218074">
<property type="protein sequence ID" value="AAF27652.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ314875">
<property type="protein sequence ID" value="ABC40734.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315774">
<property type="protein sequence ID" value="BAG38124.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121964">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL121837">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471051">
<property type="protein sequence ID" value="EAW48525.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471051">
<property type="protein sequence ID" value="EAW48526.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471051">
<property type="protein sequence ID" value="EAW48527.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471051">
<property type="protein sequence ID" value="EAW48529.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017715">
<property type="protein sequence ID" value="AAH17715.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5027.1">
<molecule id="O43318-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5028.1">
<molecule id="O43318-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5029.1">
<molecule id="O43318-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS5030.1">
<molecule id="O43318-4"/>
</dbReference>
<dbReference type="PIR" id="JC5955">
<property type="entry name" value="JC5955"/>
</dbReference>
<dbReference type="PIR" id="JC5956">
<property type="entry name" value="JC5956"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003179.1">
<molecule id="O43318-2"/>
<property type="nucleotide sequence ID" value="NM_003188.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_663304.1">
<molecule id="O43318-1"/>
<property type="nucleotide sequence ID" value="NM_145331.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_663305.1">
<molecule id="O43318-3"/>
<property type="nucleotide sequence ID" value="NM_145332.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_663306.1">
<molecule id="O43318-4"/>
<property type="nucleotide sequence ID" value="NM_145333.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.594838"/>
<dbReference type="PDB" id="2EVA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=31-412"/>
</dbReference>
<dbReference type="PDB" id="2YIY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.49"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="4GS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="4L3P">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.68"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="4L52">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.54"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="4L53">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.55"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="4O91">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.39"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5E7R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.11"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5GJD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5GJF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5GJG">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.61"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5J7S">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5J8I">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5J9L">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.75"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5JGA">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5JGB">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5JGD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5JH6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5JK3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.37"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDB" id="5V5N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A=31-303"/>
</dbReference>
<dbReference type="PDBsum" id="2EVA"/>
<dbReference type="PDBsum" id="2YIY"/>
<dbReference type="PDBsum" id="4GS6"/>
<dbReference type="PDBsum" id="4L3P"/>
<dbReference type="PDBsum" id="4L52"/>
<dbReference type="PDBsum" id="4L53"/>
<dbReference type="PDBsum" id="4O91"/>
<dbReference type="PDBsum" id="5E7R"/>
<dbReference type="PDBsum" id="5GJD"/>
<dbReference type="PDBsum" id="5GJF"/>
<dbReference type="PDBsum" id="5GJG"/>
<dbReference type="PDBsum" id="5J7S"/>
<dbReference type="PDBsum" id="5J8I"/>
<dbReference type="PDBsum" id="5J9L"/>
<dbReference type="PDBsum" id="5JGA"/>
<dbReference type="PDBsum" id="5JGB"/>
<dbReference type="PDBsum" id="5JGD"/>
<dbReference type="PDBsum" id="5JH6"/>
<dbReference type="PDBsum" id="5JK3"/>
<dbReference type="PDBsum" id="5V5N"/>
<dbReference type="ProteinModelPortal" id="O43318"/>
<dbReference type="SMR" id="O43318"/>
<dbReference type="BioGrid" id="112748">
<property type="interactions" value="160"/>
</dbReference>
<dbReference type="CORUM" id="O43318"/>
<dbReference type="DIP" id="DIP-27523N"/>
<dbReference type="IntAct" id="O43318">
<property type="interactions" value="53"/>
</dbReference>
<dbReference type="MINT" id="MINT-88554"/>
<dbReference type="STRING" id="9606.ENSP00000358335"/>
<dbReference type="BindingDB" id="O43318"/>
<dbReference type="ChEMBL" id="CHEMBL5776"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2082"/>
<dbReference type="iPTMnet" id="O43318"/>
<dbReference type="PhosphoSitePlus" id="O43318"/>
<dbReference type="BioMuta" id="MAP3K7"/>
<dbReference type="EPD" id="O43318"/>
<dbReference type="MaxQB" id="O43318"/>
<dbReference type="PaxDb" id="O43318"/>
<dbReference type="PeptideAtlas" id="O43318"/>
<dbReference type="PRIDE" id="O43318"/>
<dbReference type="DNASU" id="6885"/>
<dbReference type="Ensembl" id="ENST00000369325">
<molecule id="O43318-3"/>
<property type="protein sequence ID" value="ENSP00000358331"/>
<property type="gene ID" value="ENSG00000135341"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369327">
<molecule id="O43318-4"/>
<property type="protein sequence ID" value="ENSP00000358333"/>
<property type="gene ID" value="ENSG00000135341"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369329">
<molecule id="O43318-1"/>
<property type="protein sequence ID" value="ENSP00000358335"/>
<property type="gene ID" value="ENSG00000135341"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000369332">
<molecule id="O43318-2"/>
<property type="protein sequence ID" value="ENSP00000358338"/>
<property type="gene ID" value="ENSG00000135341"/>
</dbReference>
<dbReference type="GeneID" id="6885"/>
<dbReference type="KEGG" id="hsa:6885"/>
<dbReference type="UCSC" id="uc003pnz.3">
<molecule id="O43318-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6885"/>
<dbReference type="DisGeNET" id="6885"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000135341.17"/>
<dbReference type="GeneCards" id="MAP3K7"/>
<dbReference type="HGNC" id="HGNC:6859">
<property type="gene designation" value="MAP3K7"/>
</dbReference>
<dbReference type="HPA" id="HPA007633"/>
<dbReference type="MalaCards" id="MAP3K7"/>
<dbReference type="MIM" id="157800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="602614">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617137">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O43318"/>
<dbReference type="OpenTargets" id="ENSG00000135341"/>
<dbReference type="PharmGKB" id="PA30603"/>
<dbReference type="eggNOG" id="KOG0192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00900000140790"/>
<dbReference type="HOGENOM" id="HOG000231735"/>
<dbReference type="HOVERGEN" id="HBG003485"/>
<dbReference type="InParanoid" id="O43318"/>
<dbReference type="KO" id="K04427"/>
<dbReference type="OMA" id="PARSHPW"/>
<dbReference type="OrthoDB" id="EOG091G03QO"/>
<dbReference type="PhylomeDB" id="O43318"/>
<dbReference type="TreeFam" id="TF105116"/>
<dbReference type="Reactome" id="R-HSA-1169091">
<property type="pathway name" value="Activation of NF-kappaB in B cells"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168638">
<property type="pathway name" value="NOD1/2 Signaling Pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-202424">
<property type="pathway name" value="Downstream TCR signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871837">
<property type="pathway name" value="FCERI mediated NF-kB activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4086398">
<property type="pathway name" value="Ca2+ pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-445989">
<property type="pathway name" value="TAK1 activates NFkB by phosphorylation and activation of IKKs complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-446652">
<property type="pathway name" value="Interleukin-1 family signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450302">
<property type="pathway name" value="activated TAK1 mediates p38 MAPK activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-450321">
<property type="pathway name" value="JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357956">
<property type="pathway name" value="TNFR1-induced NFkappaB signaling pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607764">
<property type="pathway name" value="CLEC7A (Dectin-1) signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937042">
<property type="pathway name" value="IRAK2 mediated activation of TAK1 complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937072">
<property type="pathway name" value="TRAF6 mediated induction of TAK1 complex"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-975163">
<property type="pathway name" value="IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation"/>
</dbReference>
<dbReference type="SignaLink" id="O43318"/>
<dbReference type="SIGNOR" id="O43318"/>
<dbReference type="ChiTaRS" id="MAP3K7">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O43318"/>
<dbReference type="GeneWiki" id="MAP3K7"/>
<dbReference type="GenomeRNAi" id="6885"/>
<dbReference type="PRO" id="PR:O43318"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000135341"/>
<dbReference type="CleanEx" id="HS_MAP3K7"/>
<dbReference type="ExpressionAtlas" id="O43318">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O43318">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005671">
<property type="term" value="C:Ada2/Gcn5/Ada3 transcription activator complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000287">
<property type="term" value="F:magnesium ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0004709">
<property type="term" value="F:MAP kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097110">
<property type="term" value="F:scaffold protein binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0000187">
<property type="term" value="P:activation of MAPK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000186">
<property type="term" value="P:activation of MAPKK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007250">
<property type="term" value="P:activation of NF-kappaB-inducing kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043276">
<property type="term" value="P:anoikis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043966">
<property type="term" value="P:histone H3 acetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007252">
<property type="term" value="P:I-kappaB phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007254">
<property type="term" value="P:JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002755">
<property type="term" value="P:MyD88-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002756">
<property type="term" value="P:MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070423">
<property type="term" value="P:nucleotide-binding oligomerization domain containing signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032743">
<property type="term" value="P:positive regulation of interleukin-2 production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043507">
<property type="term" value="P:positive regulation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016239">
<property type="term" value="P:positive regulation of macroautophagy"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0050870">
<property type="term" value="P:positive regulation of T cell activation"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002726">
<property type="term" value="P:positive regulation of T cell cytokine production"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002223">
<property type="term" value="P:stimulatory C-type lectin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0051403">
<property type="term" value="P:stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0050852">
<property type="term" value="P:T cell receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0007223">
<property type="term" value="P:Wnt signaling pathway, calcium modulating pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017421">
<property type="entry name" value="MAPKKK7"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR26392:SF74">
<property type="entry name" value="PTHR26392:SF74"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF038168">
<property type="entry name" value="MAPKKK7"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0346">Stress response</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Mitogen-activated protein kinase kinase kinase 7" id="PRO_0000086252">
<location>
<begin position="1"/>
<end position="606"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="16">
<location>
<begin position="36"/>
<end position="291"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="16">
<location>
<begin position="42"/>
<end position="50"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with MAPK8IP1" evidence="14">
<location>
<begin position="1"/>
<end position="300"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="8"/>
<end position="14"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="16 17">
<location>
<position position="156"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="63"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="55">
<location>
<position position="184"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="20 31 39 40">
<location>
<position position="187"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="19 20">
<location>
<position position="192"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="367"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 8 9 11 12">
<location>
<position position="389"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 5 6 7 8 9 10 11 12 13">
<location>
<position position="439"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="455"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="42">
<location>
<position position="72"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 1A and isoform 1D." id="VSP_004886" evidence="50 51 52 53">
<location>
<begin position="404"/>
<end position="430"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 1C and isoform 1D." id="VSP_004887" evidence="50 53">
<original>PLAPCPNSKE</original>
<variation>ARTSCRTGPG</variation>
<location>
<begin position="509"/>
<end position="518"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 1C and isoform 1D." id="VSP_004888" evidence="50 53">
<location>
<begin position="519"/>
<end position="606"/>
</location>
</feature>
<feature type="sequence variant" description="In CSCF." id="VAR_077341" evidence="45">
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD2; dbSNP:rs886039231." id="VAR_077342" evidence="44">
<original>E</original>
<variation>Q</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD2; dbSNP:rs886039232." id="VAR_077343" evidence="44">
<original>V</original>
<variation>E</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In CSCF; dbSNP:rs886039235." id="VAR_077344" evidence="45">
<original>G</original>
<variation>C</variation>
<location>
<position position="110"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD2; increases autophosphorylation; no effect on MAPK signaling; no effect on NF-kappa-B signaling; dbSNP:rs886039233." id="VAR_077345" evidence="44">
<original>G</original>
<variation>R</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="sequence variant" description="In CSCF; dbSNP:rs886039237." id="VAR_077346" evidence="45">
<original>W</original>
<variation>R</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In FMD2; does not affect interaction with TAB2; does not affect homodimerization; increases autophosphorylation; increases MAPK signaling; increases NF-kappa-B signaling; dbSNP:rs886039230." id="VAR_077347" evidence="44">
<original>P</original>
<variation>L</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of kinase activity." evidence="25">
<original>K</original>
<variation>W</variation>
<location>
<position position="63"/>
</location>
</feature>
<feature type="mutagenesis site" description="Enhances autophosphorylation; Alters MAPK signaling." evidence="44">
<original>P</original>
<variation>R</variation>
<variation>A</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="36"/>
<end position="43"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="46"/>
<end position="55"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="58"/>
<end position="64"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="70"/>
<end position="83"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="92"/>
<end position="95"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="97"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="101"/>
<end position="105"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="112"/>
<end position="117"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="119"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="127"/>
<end position="145"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="148"/>
<end position="150"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="159"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="162"/>
<end position="165"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="166"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="170"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="182"/>
<end position="186"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="193"/>
<end position="195"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="198"/>
<end position="201"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="209"/>
<end position="217"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="228"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="239"/>
<end position="245"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="259"/>
<end position="263"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="267"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="271"/>
<end position="273"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="281"/>
<end position="289"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="292"/>
<end position="295"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="300"/>
<end position="302"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2EVA"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5GJF"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5JGA"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18088087"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18691976"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250"/>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q62073"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10094049"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10702308"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10838074"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11104763"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11118615"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11460167"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12242293"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12589052"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12804775"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12874243"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14670075"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15894542"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16289117"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16845370"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16893890"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17079228"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17449468"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17548520"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18286207"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18758450"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19521662"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19675569"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21512573"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22084099"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22406003"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26334375"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27426733"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27426734"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28827540"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8638164"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8663074"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9079627"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11118615"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9480845"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000305"/>
<evidence key="55" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="10838074"/>
</source>
</evidence>
<sequence length="606" mass="67196" checksum="3D8F8147CD174013" modified="1998-06-01" version="1">
MSTASAASSSSSSSAGEMIEAPSQVLNFEEIDYKEIEVEEVVGRGAFGVVCKAKWRAKDV
AIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAE
PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC
DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM
WAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY
PCQYSDEGQSNSATSTGSFMDIASTNTSNKSDTNMEQVPATNDTIKRLESKLLKNQAKQQ
SESGRLSLGASRGSSVESLPPTSEGKRMSADMSEIEARIAATTAYSKPKRGHRKTASFGN
ILDVPEIVISGNGQPRRRSIQDLTVTGTEPGQVSSRSSSPSVRMITTSGPTSEKPTRSHP
WTPDDSTDTNGSDNSIPMAYLTLDHQLQPLAPCPNSKESMAVFEQHCKMAQEYMKVQTEI
ALLLQRKQELVAELDQDEKDQQNTSRLVQEHKKLLDENKSLSTYYQQCKKQLEVIRSQQQ
KRQGTS
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>